论文期刊

取消

高级检索

检索历史清除

首页> Japanese journal of clinical oncology> EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancer.

EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Beina,Hui

第一单位： Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

作者： Beina,Hui ^[1] ; Jingping,Zhang ^[2] ; Xiaobo,Shi ^[1] ; Fangfang,Xing ^[3] ; Yang W,Shao ^[4] ; Yuanyuan,Wang ^[5] ; Xiaozhi,Zhang ^[6] ; Shuwen,Wang ^[1]

作者单位： Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. ^[1] Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. ^[2] Department of Laboratory Medicine, Sports trauma Hospital, Xi'an, Shaanxi, China. ^[3] Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China. ^[4] School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China. ^[5] Department of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. ^[6]

关键词 EML4-ALK fusion gene alectinib next generation sequencing ovarian cancer targeted therapy

主题词卡唑类(Carbazoles);女(雌)性(Female);人类(Humans);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);卵巢肿瘤(Ovarian Neoplasms);哌啶类(Piperidines);蛋白激酶抑制剂(Protein Kinase Inhibitors);治疗结果(Treatment Outcome)

DOI 10.1093/jjco/hyaa156

PMID 32845005

发布时间 2021-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Japanese journal of clinical oncology

Japanese journal of clinical oncology

2020年50卷12期

1470-1474页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷